Search Results for "CT P6 Celltrion"

06:20 EDT 27th May 2016 | BioPortfolio

Matching Channels


Matching News

INTERVIEW: The Biosimilar Brain - Celltrion’s Dr. Stanley Hong

South Korean firm Celltrion Healthcare is a pioneer in the biosimilar space, having launched the world's first monoclonal antibody biosimilar, Remsima (infliximab), which was rolled out across Europe ...

Early Approvals Pave Smooth Biosimilar Path For Celltrion, Samsung

South Korea's Celltrion and Samsung Bioepis are competing hard to grab a slice of the burgeoning global biosimilar market. Celltrion’s Remicade biosimilar has already been widely launched and may on...

Celltrion Expects Korea Rituximab Approval Despite Biogen Action

Biogen moves to halt Celltrion from selling a rituximab biosimilar in South Korea by seeking a patent scope confirmation trial as the South Korean firm gears up to launch its second biosimilar. But Ce...

Celltrion Adopts Medidata Clinical Cloud

Medidata's ClinicalCloud will provide scalable technology to Celltrion's biosimilars development programs. Date:  Thu, 2016-01-21 (All day) ...

Korea stock? Celltrion stores Remicade biosimilar but minimises risks

Celltrion’s supply chain and warehousing procedures ensure the safe storage of Remicade biosimilars as demand fluctuates across markets, the drugmaker says.

US Panel Favors Celltrion’s Infliximab But Skeptical On Cost Savings

With the favorable backing of a US FDA advisory panel on Feb. 9, which followed a positive review by regulators, Celltrion and its partner, Pfizer unit Hospira, are well on their way to putting the fi...

Celltrion submits rituximab biosimilar application to EMA

South Korean biotechnology company Celltrion has, according to Business Korea, submitted a second biosimilar application to the European Medicines Agency (EMA).

Celltrion seeks EU approval for rituximab biosimilar

Korean drugmaker Celltrion filed for approval from the European Medicines Agency for CT-P10, a biosimilar for the monoclonal  -More- 

Matching PubMed Articles

Search Whole site using Google

Quick Search
Advertisement Advertisement